Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 147 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No Intervention: Observational Cohort Clear all

Conditions: Sleep Initiation and Maintenance Disorders, Pregnancy
Interventions: No Intervention; Other
Lead sponsor: Eisai Inc.; Industry
Eligibility: 16 Years to 49 Years · Female only
Enrollment: 861 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Nutley, New Jersey

Conditions: Acute Lymphoblastic Leukemia, Brain Tumor
Interventions: Observational; Other
Lead sponsor: Columbia University; Other
Eligibility: 3 Years to 21 Years
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 1
States / cities: New York, New York

Conditions: Danon Disease
Interventions: No intervention; Other
Lead sponsor: Rocket Pharmaceuticals Inc.; Industry
Eligibility: 8 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 9
States / cities: Phoenix, Arizona • La Jolla, California • Aurora, Colorado + 6 more

Conditions: Staphylococcus Aureus
Interventions: CA-MRSA Decolonization; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: Female only
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aging
Interventions: Observational; Other
Lead sponsor: Buck Institute for Research on Aging; Other
Eligibility: 65 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Novato, California

Conditions: Rotator Cuff Tear
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 495 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: No intervention; Other
Lead sponsor: Takeda; Industry
Eligibility: 65 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Depression, Depression, Bipolar
Interventions: Observational Study; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 10 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2036
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Kidney Diseases, Sickle Cell Disease
Interventions: No intervention; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 5 Years to 29 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: MPH (Concerta), MPH (Ritalin), Atomoxetine (ATO), Guanfacine (GFC); Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: Not listed
Enrollment: 17,418 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Titusville, New Jersey

Conditions: Gait
Interventions: None- Observational Study; Other
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 60 Years
Enrollment: 244 participants
Timeline: 2019 – 2024
U.S. locations: 10
States / cities: Lexington, Kentucky • Baltimore, Maryland • Bethesda, Maryland + 7 more

Conditions: Pregnancy, Obesity, Overweight
Interventions: No Intervention; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 728 participants
Timeline: 2023 – 2032
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Transthyretin Amyloidosis, Transthyretin Amyloidosis With Cardiomyopathy, Transthyretin Amyloidosis With Polyneuropathy
Interventions: None ( observational study ); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alpha1-Antitrypsin Deficiency
Interventions: No Intervention; Other
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 3
States / cities: Gainesville, Florida • Charleston, South Carolina • Nashville, Tennessee

Conditions: Acne-prone Skin, Skin Disease
Interventions: PRX S topical cosmetic treatment, WiQo home care regimen (Nourishing Cream; Balancing Cream); Other
Lead sponsor: WiQo S.p.A.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Leawood, Kansas • Tulsa, Oklahoma

Conditions: Respiratory Failure, Respiratory Arrest, Respiratory Distress Syndrome, Acute Respiratory Failure, Acute Respiratory Failure With Hypoxia, Acute Respiratory Failure With Hypercapnia, Acute Respiratory Failure Post Surgical, Acute Respiratory Failure Postprocedural, Acute Respiratory Failure Following Trauma and Surgery, Acute Respiratory Failure Requiring Reintubation, Acute Respiratory Failure Post Traumatic, Acute Respiratory Decompensation, Shock, Shock, Septic, Shock, Cardiogenic, Acute Cardiac Failure, Multi Organ Failure, Acute Kidney Failure
Interventions: Observational retrospective cohort to describe data validity; and Data reliability; and Completeness of the data; Other
Lead sponsor: Efficacy Care R&D Ltd; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 50,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Non Small Cell Lung Cancer
Interventions: Observational; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Postmenopausal, Female
Interventions: There will be no intervention.; Other
Lead sponsor: Florida State University; Other
Eligibility: 55 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Chronic Pain, Chronic Pain (Back / Neck)
Interventions: No Intervention: Observational Cohort; Other
Lead sponsor: Evidence In Motion; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Story City, Iowa

Conditions: Brain Concussion
Interventions: Concussion; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 10 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Infant, Very Low Birth Weight
Interventions: Observational - no intervention; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 3 Days
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Opioid Overdose
Interventions: Observation only; Other
Lead sponsor: Member Companies of the Opioid PMR Consortium; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 808,455 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Wilmington, Delaware • Boston, Massachusetts • Portland, Oregon + 1 more

Conditions: Periodontal Disease, Staging, Salivary Markers, Diagnosis
Interventions: This is an observational study, no intervention is anticipated.; Other
Lead sponsor: Midwestern University; Other
Eligibility: 30 Years to 99 Years
Enrollment: 106 participants
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: Vedolizumab IV, No Intervention; Drug · Other
Lead sponsor: Takeda; Industry
Eligibility: 2 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 22
States / cities: Mobile, Alabama • Phoenix, Arizona • Los Angeles, California + 19 more

Search by objective public record fields.

A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

European Prospective Investigation Into Childhood Cancer

Danon Disease Natural History Study

A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA

Molecular Optimization Via Exercise (MOVE)

The Natural History of Asymptomatic Rotator Cuff Tears

A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease

Dallas 2K: A Natural History Study of Depression

Sickle Cell Uric Acid (SCUA) - Cohort Repository

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan

The Mobility Toolkit: Electronically Augmented Assessment of Functional Recovery Following Lower-extremity Trauma

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin

Postoperative Respiratory Abnormalities

Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab

How Seasons Affect Kidney Health in Post-Menopausal Females

Chronic Pain, Emotions and Professional Football

Tissue Repository and Master Database for Concussion Biomarker and Risk Calculator Development

Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk

Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics

Salivary Markers in Periodontal Disorders

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)